🇺🇸 FDA
Company

SPRUCE

SPRUCE BIOSCIENCES, INC.

SPRB pharma USA

Quick answer

SPRUCE is a pharma company (SPRB) headquartered in SOUTH SAN FRANCISCO, CA, USA with 5 tracked pipeline programs.

Pipeline (5)

project

Tralesinidase alfa (TA)

MPS IIIB

Phase 3 · small_molecule · active

1 trials project

SPR001

Congenital Adrenal Hyperplasia

Phase 2 · small_molecule · completed

2 trials project

Tildacerfont

Congenital Adrenal Hyperplasia

Phase 2 · small_molecule · terminated

1 trials project

Tildacerfont

Polycystic Ovary Syndrome

Phase 2 · small_molecule · terminated

1 trials project

Tildacerfont/Placebo

Congenital Adrenal Hyperplasia

Phase 2 · small_molecule · terminated

2 trials

Patents (8)

patent

US 12115166

Corticotropin releasing factor receptor antagonists

Expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12098152

Methods and compositions for treating polycystic ovary syndrome

Expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11858932

Methods and compositions for treating polycystic ovary syndrome

Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11351177

Corticotropin releasing factor receptor antagonists

Expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11344557

Corticotropin releasing factor receptor antagonists

Expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11311549

Corticotropin releasing factor receptor antagonists

Expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11304950

Methods for treating testicular and ovarian adrenal rest tumors

Expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11007201

Corticotropin releasing factor receptor antagonists

Expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)